Cambridge Nutritional Sciences (LON:CNSL) Insider Acquires £3,375.52 in Stock

Cambridge Nutritional Sciences plc (LON:CNSLGet Free Report) insider Jeremy Millard purchased 168,776 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were bought at an average cost of GBX 2 per share, with a total value of £3,375.52.

Cambridge Nutritional Sciences Stock Up 11.1%

Shares of CNSL opened at GBX 2.50 on Wednesday. Cambridge Nutritional Sciences plc has a fifty-two week low of GBX 1.86 and a fifty-two week high of GBX 4.38. The company’s fifty day moving average is GBX 2.73 and its two-hundred day moving average is GBX 3.08. The firm has a market cap of £5.95 million, a PE ratio of 3.57 and a beta of 3.89.

Cambridge Nutritional Sciences (LON:CNSLGet Free Report) last released its quarterly earnings data on Monday, November 10th. The company reported GBX (0.20) EPS for the quarter. Cambridge Nutritional Sciences had a negative return on equity of 3.34% and a negative net margin of 3.36%. As a group, equities research analysts anticipate that Cambridge Nutritional Sciences plc will post 0.036865 earnings per share for the current year.

About Cambridge Nutritional Sciences

(Get Free Report)

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Further Reading

Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.